1nHealth

1nHealth is a United States-based clinical trial patient recruitment and enrollment company. The company provides services to pharmaceutical sponsors, biotechnology firms, and clinical research organizations (CROs) to support participant recruitment, screening, and engagement in clinical studies.

Its services focus on accelerating study enrollment timelines and improving recruitment predictability by managing outreach, pre-screening, and patient qualification processes. The company operates within the broader clinical research and decentralized trial ecosystem, where sponsors increasingly rely on specialized vendors to address enrollment challenges in complex and multi-site studies.

History

1nHealth, Inc. began operations in 2019 and is incorporated in Florida, according to public business records. The company’s name references the “n=” notation commonly used in clinical research to denote the number of participants required for a study.

Services

1nHealth provides services related to clinical trial enrollment and patient engagement. According to company materials, its offerings include study feasibility validation, patient recruitment campaign development, pre-screening and qualification, and enrollment support. The company describes its model as assuming operational responsibility for recruitment performance rather than functioning solely as a marketing vendor.

The company also markets a data platform referred to as “1nData,” which it describes as providing enrollment performance insights and analytics for sponsors and research sites.

Industry activity

Public filings by biotechnology company NRX Pharmaceuticals in 2023 referenced 1nHealth as a contracted partner to support patient recruitment efforts for an expanded clinical trial program. The filing described 1nHealth’s role as part of a broader decentralized trial infrastructure alongside a contract research organization.

Industry news, coverage, and commentary

In April 2023, *pharmaphorum*, an independent pharmaceutical news publication, reported on a collaboration between 1nHealth and The Mighty focused on supporting patients who are not eligible for specific clinical trials. The article described how the partnership routes individuals who fail screening eligibility to community support resources on The Mighty’s platform, and quoted 1nHealth’s CEO Dan Brenner discussing the importance of providing support even to those who cannot participate in a trial.

In May 2023, in the context of news that CVS Health would be winding down its clinical trial services business, Steve Wimmer, Vice President of Partnerships at 1nHealth, was quoted in an article on BioSpace commenting on the strategic shift. Wimmer described the decision by CVS Health as “shocking” given the company’s relatively recent entry into the clinical trial space and its reported growth, and noted his understanding that the patient recruitment and real-world data collection components of CVS’ initiative had been generating revenue at the time of the announcement. The article discussed CVS Health’s decision to shutter its clinical trial division, launched in May 2021 and aimed at expanding access to research participation, and included industry perspectives on the challenges of decentralized clinical trial delivery.

Industry collaborations

In January 2022, Politico reported on changes to Facebook’s advertising policies affecting medical research recruitment and quoted 1nHealth CEO Dan Brenner regarding the potential impact on clinical trial enrollment efforts. In the article, Brenner stated that restrictions on advertising could make participant recruitment more difficult for research organizations that relied on social media outreach to enroll clinical trials.

In March 2022, Fierce Biotech reported that 1nHealth and ObvioHealth announced a collaboration intended to assist drug developers facing challenges with decentralized and hybrid clinical trials. The article described the partnership as focusing on improving coordination between patient recruitment and decentralized trial operations as sponsors expanded remote and site-less study models.

1nHealth has also published sponsored articles in the trade publication BioPharma Dive on topics related to clinical trial enrollment, recruitment risk planning, and patient retention.

Awards and recognition

In December 2022, Clinical Research News named 1nHealth a finalist for the 2023 Participant Engagement Award for its campaign “Have The Colon Conversation,” described as an “omni-channel digital outreach campaign to challenge older adults to get their first screening colonoscopy.” The article said the finalists would present at the Summit for Clinical Ops Executives (SCOPE) Summit in Orlando, Florida (February 6–9, 2023), with winners announced following live presentations and judging at the event.

Partnerships and collaborations

In August 2021, 1nHealth and THREAD announced a strategic partnership to optimize participant recruitment for decentralized clinical trials. According to a press release distributed by PR Newswire, the agreement was intended to combine 1nHealth’s digital recruitment capabilities with THREAD’s digital engagement and relationship management platform to address recruitment and retention outcomes in decentralized trial models.

In 2022, 1nHealth announced a collaboration with Curavit Clinical Research to support patient recruitment for decentralized clinical trials. According to a press release distributed by PR Newswire, the partnership focused on improving enrollment timelines through digital patient recruitment services for Curavit’s clinical programs.

1nHealth is also listed by IQVIA as a partner in IQVIA's One Home for Sites Partner Program. The program brings together technology and service providers that integrate with IQVIA’s One Home for Sites platform, which is designed to streamline workflows and technology access for clinical research sites.

Company announcements

In 2025, 1nHealth announced updates to its corporate website and the launch of a resource hub called “The Site Exchange” described by the company as a knowledge platform for clinical trial sites. These announcements were distributed through press release services.

1nHealth also hosts an annual "Patient Engagement Leaders Awards" recognizing 25 industry leaders in patient engagement, determined by peer nominations throughout the clinical research industry.

See also

Clinical trial

Patient recruitment

Decentralized clinical trials

References

This article "1nHealth" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:1nHealth. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

---